Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Bexsero TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: meningococcal b 4 component vaccine
Brand name
(ARTG)
: BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
BEXSERO is indicated for active immunisation against invasive disease caused by N. meningitidis group B strains. For information on protection against specific group B strains see Section 5.1 PHARMACODYNAMIC PROPERTIES. BEXSERO is indicated for vaccination of individuals from 2 months of age and older.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, suspension
- Intramuscular
- White suspension
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x pre-filled syringe without needle pack
- 10 x pre-filled syringes without needle pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Child and Family Health Service • New Baby Resource Pack
Congratulations on the birth of your baby! Being a parent can be exciting, rewarding and challenging at times
Read more on Child and Family Health Service website
Vaxelis | NCIRS
DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) – frequently asked questions NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Key points There are two hexavalent combination vaccines – Vaxelis® and Infanrix hexa® – available on the National Immunisation Program (NIP) that protect against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, polio and Haemophilus influenzae type b (Hib)
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Meningococcal vaccine | Australian Government Department of Health and Aged Care
Information about meningococcal vaccines, who they are recommended for, how and where to get vaccinated. If you're eligible, you can get the meningococcal vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health and Aged Care website
Meningococcal disease - myDr.com.au
Meningococcal disease is a rare but serious illness, occurring mostly in winter and early spring in Australia. Find out what causes this disease and how to prevent it.
Read more on MyDoctor website
Childhood immunisation - Better Health Channel
Being immunised from an early age helps protect your child against serious childhood infections.
Read more on Better Health Channel website
Meningitis - Brain Foundation
Meningitis is a rare but serious infection of the membranes that cover the brain & spinal cord. It is caused by bacteria, fungi, or viruses.
Read more on Brain Foundation website
Travel vaccinations - myDr.com.au
Travel immunisations are important in pre-trip planning to certain countries. Vaccinations that travellers may need include tetanus and diphtheria, hepatitis A and B, and typhoid vaccinations.
Read more on MyDoctor website
Top results
New resource: Meningococcal B vaccination – a guide for healthcare providers | NCIRS
This new NCIRS resource provides a general guide for healthcare providers to facilitate effective communication about meningococcal B (Men B) vaccination. The resource has a focus on Aboriginal and Torres Strait Islander children. Under the National Immunisation Program changes that came into effect from 1 July 2020, MenB vaccine (Bexsero) is now funded for all Aboriginal and Torres Strait Islander children from 2 months of age. A catch-up program is also available for Aboriginal and Torres Strait Islander children aged
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Meningococcal Disease Guide - Immunisation Coalition
About Meningococcal Disease Meningococcal Disease Symptoms What Causes Meningococcal Disease? Who Is Most Affected? Risk Factors Complications Quadrivalent Meningococcal Vaccine Meningococcal B Vaccine Meningococcal C Conjugate Vaccines Download the Guide pdf About Meningococcal Disease Meningococcal disease progresses very rapidly
Read more on Immunisation Coalition website
